<http://schema.org/description>
"Diversification has fallen somewhat out of favor in Big Pharma, as many companies are looking to a smaller number of larger therapeutic areas to generate better growth and cash flow. Merck  is"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2014/02/06/merck-co-inc-pushing-the-throttle-on-oncology/20824876/>